Clinical Trials Directory

Trials / Completed

CompletedNCT00463671

Hyperbaric Oxygen, Oxidative Stress, NO Bioavailability and Tissue Oxygenation

The Relation Between Hyperbaric Oxygen, Oxidative Stress, NO Bioavailability and Tissue Oxygenation in Diabetic Patients Suffering From Foot Ulcers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (planned)
Sponsor
Assaf-Harofeh Medical Center · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hyperbaric oxygen therapy (HBOT) increases tissue oxygenation and serves as an adjunct therapy for diabetic wounds. However, some patients have insufficient increase or even paradoxical decrease in tissue O2 due to vasoconstriction. The aim of the present study was to investigate the pathophysiology responsible for the different consequences of HBOT and to evaluate the effect of N-acetylcysteine (NAC) on these changes. Methods: Prospective, randomized, cross-over trial including fifty diabetic patients with non-healing ulcers. All patients had two HBOT (100%oxygen, 2ATA) with NAC at the first or the second evaluation. At the beginning and at the end of each evaluation, ulcer oxygenation and plasma levels of malondialdehyde (MDA), total anti-oxidant status (TAOS) and nitric oxide (NO) were measured. Patients with ulcer oxygenation above 200mmHg, were subjected to complete HBOT protocol.

Conditions

Interventions

TypeNameDescription
DRUGN-acetylcysteine

Timeline

Start date
2003-12-01
Completion
2005-09-01
First posted
2007-04-20
Last updated
2008-10-17

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00463671. Inclusion in this directory is not an endorsement.